GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) mimic this hormone to slow gastric emptying, reducing appetite and curbing food cravings
By slowing gastric emptying and altering gut motility, semaglutide can change the guts microbial landscape, potentially allowing yeast to thrive
Understanding the tools, terminologies, and emerging trends in these areas is essential for researchers and manufacturers alike to develop safe, effective, and economically viable therapies
Initially approved for type 2 diabetes, they are now also FDA-approved for weight management, cardiovascular risk reduction, obstructive sleep apnea, and metabolic-associated liver disease (steatohepatitis)
Insurance Accepts insurance for membership (partially) Accepts insurance for prescriptions Offers an insurance concierge Cash pay only Cancellations, Refunds, and Commitment Terms No long-term membership required
1 Nasal works